Medicines, 2013
Shortlist up to four to read them side by side.
1,376 medicine recalls FDA’s Enforcement Report published in 2013, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,376of 1,376 medicine recallsshown with your filters
The list
- Medicine recall Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Injection vehicle, 120 ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Medroxyprogesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Methionine/Choline/Inositol/ B-12, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Methylcobalamin 1250 mcg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Methylcobalamin 12.5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Mitomycin (modified) 0.02% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Ophthalmic dilation gel, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Ophthalmic dilation gel (MAR), Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Phenylephrine-cyclopentolate, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Progesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Sodium Chloride Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 200 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding Pharmacy, 318 Baston Road,… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 25 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 50 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test Cyp 50 mg-estradiol blend 22 mg, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Test cyp 75 mg-estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Tetracaine(buffered) 0.25% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA… Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Vancomycin 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Class IIFDA’s classJul 10, 2013in FDA’s Enforcement Report3 statesnamed in where it went PublishedJul 10, 2013ClassClass IIStatusTerminatedWhereFlorida, Georgia and South Carolina
- Medicine recall Derma-Smoothe/FS (fluocinolone acetonide) Topical Oil (SCALP OIL), 0.01 %, 118.28 mL Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm’s routine testing. Class IIIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, Polyolefin Flexible Container, a) 500 mL (NDC 0409-7983-30), b) 1000 mL… Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 70% Dextrose Injection USP, 2000 mL Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 0.45% Sodium Chloride Injection, USP Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-7922-30), by Hospira, Inc., Lake… Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL… Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 20% Dextrose Injection, USP, a) 500 mL Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Irrigation, USP, 3000 mL Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 1.5% Glycine Irrigation, USP, 3000 mL Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Class IIFDA’s classJul 3, 2013in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 3, 2013ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.